Literature DB >> 22124367

Urological cancer: Time for another rethink on prostate cancer screening.

Andrew J Vickers, Hans Lilja.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 22124367     DOI： 10.1038/nrclinonc.2011.181

Source DB:  PubMed          Journal:  Nat Rev Clin Oncol        ISSN： 1759-4774            Impact factor:   66.675


× No keyword cloud information.
  10 in total

Review 1.  Screening for prostate cancer: a review of the evidence for the U.S. Preventive Services Task Force.

Authors:  Roger Chou; Jennifer M Croswell; Tracy Dana; Christina Bougatsos; Ian Blazina; Rongwei Fu; Ken Gleitsmann; Helen C Koenig; Clarence Lam; Ashley Maltz; J Bruin Rugge; Kenneth Lin
Journal:  Ann Intern Med       Date:  2011-10-07       Impact factor: 25.391

2.  Mortality results from the Göteborg randomised population-based prostate-cancer screening trial.

Authors:  Jonas Hugosson; Sigrid Carlsson; Gunnar Aus; Svante Bergdahl; Ali Khatami; Pär Lodding; Carl-Gustaf Pihl; Johan Stranne; Erik Holmberg; Hans Lilja
Journal:  Lancet Oncol       Date:  2010-07-02       Impact factor: 41.316

3.  Population-based patterns and predictors of prostate-specific antigen screening among older men in the United States.

Authors:  Michael W Drazer; Dezheng Huo; Mara A Schonberg; Aria Razmaria; Scott E Eggener
Journal:  J Clin Oncol       Date:  2011-03-28       Impact factor: 44.544

4.  Balancing the harms and benefits of early detection of prostate cancer.

Authors:  Pim J van Leeuwen; David Connolly; Teuvo L J Tammela; Anssi Auvinen; Ries Kranse; Monique J Roobol; Fritz H Schroder; Anna Gavin
Journal:  Cancer       Date:  2010-10-15       Impact factor: 6.860

5.  Prediction of significant prostate cancer diagnosed 20 to 30 years later with a single measure of prostate-specific antigen at or before age 50.

Authors:  Hans Lilja; Angel M Cronin; Anders Dahlin; Jonas Manjer; Peter M Nilsson; James A Eastham; Anders S Bjartell; Peter T Scardino; David Ulmert; Andrew J Vickers
Journal:  Cancer       Date:  2010-10-19       Impact factor: 6.860

6.  Time trends and local variation in primary treatment of localized prostate cancer.

Authors:  Matthew R Cooperberg; Jeanette M Broering; Peter R Carroll
Journal:  J Clin Oncol       Date:  2010-02-01       Impact factor: 44.544

7.  Screening and prostate-cancer mortality in a randomized European study.

Authors:  Fritz H Schröder; Jonas Hugosson; Monique J Roobol; Teuvo L J Tammela; Stefano Ciatto; Vera Nelen; Maciej Kwiatkowski; Marcos Lujan; Hans Lilja; Marco Zappa; Louis J Denis; Franz Recker; Antonio Berenguer; Liisa Määttänen; Chris H Bangma; Gunnar Aus; Arnauld Villers; Xavier Rebillard; Theodorus van der Kwast; Bert G Blijenberg; Sue M Moss; Harry J de Koning; Anssi Auvinen
Journal:  N Engl J Med       Date:  2009-03-18       Impact factor: 91.245

8.  Prostate specific antigen concentration at age 60 and death or metastasis from prostate cancer: case-control study.

Authors:  Andrew J Vickers; Angel M Cronin; Thomas Björk; Jonas Manjer; Peter M Nilsson; Anders Dahlin; Anders Bjartell; Peter T Scardino; David Ulmert; Hans Lilja
Journal:  BMJ       Date:  2010-09-14

9.  Prostate-specific antigen-based early detection of prostate cancer--validation of screening without rectal examination.

Authors:  F H Schröder; M Roobol-Bouts; A N Vis; T van der Kwast; R Kranse
Journal:  Urology       Date:  2001-01       Impact factor: 2.649

10.  Nationwide population-based study on 30-day mortality after radical prostatectomy in Sweden.

Authors:  Sigrid Carlsson; Jan Adolfsson; Ola Bratt; Jan-Erik Johansson; Christer Ahlstrand; Erik Holmberg; Pär Stattin; Jonas Hugosson
Journal:  Scand J Urol Nephrol       Date:  2009
  10 in total
  1 in total

1.  Limitations of basing screening policies on screening trials: The US Preventive Services Task Force and Prostate Cancer Screening.

Authors:  Ruth Etzioni; Roman Gulati; Matt R Cooperberg; David M Penson; Noel S Weiss; Ian M Thompson
Journal:  Med Care       Date:  2013-04       Impact factor: 2.983
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.